Market Cap 822.71M
Revenue (ttm) 187.34M
Net Income (ttm) -9.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.32%
Debt to Equity Ratio 0.43
Volume 1,032,800
Avg Vol 1,422,560
Day's Range N/A - N/A
Shares Out 46.01M
Stochastic %K 61%
Beta 1.04
Analysts Strong Sell
Price Target $24.75

Company Profile

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral...

Industry: Medical Devices
Sector: Healthcare
Phone: 386 462 6800
Fax: 386 462 6801
Address:
13631 Progress Boulevard, Suite 400, Alachua, United States
kgnfdeagle
kgnfdeagle Oct. 3 at 4:30 PM
$AXGN Long from $18.00 -- Zacks Homerun pick.
1 · Reply
Quantumup
Quantumup Oct. 2 at 11:05 AM
Canaccord Genuity yesterday reiterated $AXGN at a Buy rating and a $24 price target. $XBI $IBB Canaccord Genuity today reiterated AxoGen, Inc. (AXGN) at a Buy rating and $24 price target. Canaccord Genuity's note from y'day also answers some questions y'all may have on the Shutdown in regards to the HHS/FDA and what in means to the Healthcare Industry. Canaccord Genuity said in its notes to investors:
0 · Reply
LuckEtradER
LuckEtradER Oct. 1 at 11:36 PM
0 · Reply
dustin1101
dustin1101 Oct. 1 at 2:31 PM
$AXGN Weak handed buyers from yesterday’s H.C. W coverage are discovering this is a thin stock and they’re pounding out with 70K total volume traded.. this will turn back up IMO. Amateur hour.
1 · Reply
highnihilism
highnihilism Oct. 1 at 9:22 AM
$KBR KBR Trade Count: 20 | Total $: 6.5 K | 0.15 × 90-Day Avg $: 43.6 K | Call $: 3.5 K | Put $: 3.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $XOVR Ershares Private-Public Crossover ETF Trade Count: 11 | Total $: 3.5 K | 0.22 × 90-Day Avg $: 15.7 K | Call $: 3.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $AXGN Axogen Trade Count: 12 | Total $: 4.6 K | 0.17 × 90-Day Avg $: 26.6 K | Call $: 3.5 K | Put $: 1.1 K | % Single-Leg: 72% | % Multi-Leg: 0% | % Contingent: 28% $NVX Novonix Trade Count: 28 | Total $: 46.3 K | 28.62 × 90-Day Avg $: 1.6 K | Call $: 3.5 K | Put $: 42.8 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
JarvisFlow
JarvisFlow Sep. 30 at 10:56 AM
HC Wainwright & Co. updates rating for Axogen ( $AXGN ) to Buy, target set at 25.
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 2:04 AM
Healthcare M&A Takeout / Must-Own Basket: $AXGN $AVTR $ADMA $EVH $SGRY 🔥💪👍💵
1 · Reply
GFstocktwits
GFstocktwits Sep. 29 at 12:46 PM
$AXGN why buy a "second runner", take a look at RNV on the asx when you feel like it
0 · Reply
dustin1101
dustin1101 Sep. 24 at 7:40 PM
$AXGN Just keep buying the dips.. Added back what I sold 17.65 at 17.10 today. Steady freight train momentum as buyers continue to slowly accumulate.
0 · Reply
highnihilism
highnihilism Sep. 24 at 7:10 PM
Russell 2000 (Healthcare) → $AXGN Axogen $BMRN BioMarin Pharmaceutical $CDMO Avid Bioservices $CGEN Compugen $CHCO Community Health Systems
0 · Reply
Latest News on AXGN
Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 1:15 PM EDT - 2 months ago

Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript


Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript

May 9, 2025, 3:21 PM EDT - 5 months ago

Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript


Axogen, Inc. Reports 2025 First Quarter Financial Results

May 8, 2025, 7:05 AM EDT - 5 months ago

Axogen, Inc. Reports 2025 First Quarter Financial Results


Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 1:58 PM EST - 7 months ago

Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript


Axogen, Inc. To Host Analyst & Investor Day on March 4th

Feb 25, 2025, 7:10 AM EST - 7 months ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th


Axogen: Well Placed To Capitalize Growth At Higher Multiples

Jan 6, 2025, 8:01 PM EST - 9 months ago

Axogen: Well Placed To Capitalize Growth At Higher Multiples


Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:53 AM EST - 11 months ago

Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript


Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 2:10 PM EDT - 1 year ago

Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript


Axogen, Inc. Announces New Leadership Appointments

Aug 8, 2024, 7:05 AM EDT - 1 year ago

Axogen, Inc. Announces New Leadership Appointments


AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript

May 5, 2024, 1:21 AM EDT - 1 year ago

AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript


Axogen, Inc Reports First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Axogen, Inc Reports First Quarter 2024 Financial Results


AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 11:03 AM EST - 1 year ago

AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript


Axogen Announces Promotions on Research and Development Team

Jan 4, 2024, 4:35 PM EST - 1 year ago

Axogen Announces Promotions on Research and Development Team


Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Dec 26, 2023, 4:15 PM EST - 1 year ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors


Axogen Announces Transition of Finance Team Leadership

Dec 6, 2023, 7:00 AM EST - 1 year ago

Axogen Announces Transition of Finance Team Leadership


AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 9:49 AM EST - 2 years ago

AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Third Quarter Financial Results

Nov 7, 2023, 7:00 AM EST - 2 years ago

Axogen, Inc. Reports 2023 Third Quarter Financial Results


Axogen to Participate at Upcoming Investor Conferences

Aug 31, 2023, 7:00 AM EDT - 2 years ago

Axogen to Participate at Upcoming Investor Conferences


AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 9:34 PM EDT - 2 years ago

AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Second Quarter Financial Results

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Axogen, Inc. Reports 2023 Second Quarter Financial Results


kgnfdeagle
kgnfdeagle Oct. 3 at 4:30 PM
$AXGN Long from $18.00 -- Zacks Homerun pick.
1 · Reply
Quantumup
Quantumup Oct. 2 at 11:05 AM
Canaccord Genuity yesterday reiterated $AXGN at a Buy rating and a $24 price target. $XBI $IBB Canaccord Genuity today reiterated AxoGen, Inc. (AXGN) at a Buy rating and $24 price target. Canaccord Genuity's note from y'day also answers some questions y'all may have on the Shutdown in regards to the HHS/FDA and what in means to the Healthcare Industry. Canaccord Genuity said in its notes to investors:
0 · Reply
LuckEtradER
LuckEtradER Oct. 1 at 11:36 PM
0 · Reply
dustin1101
dustin1101 Oct. 1 at 2:31 PM
$AXGN Weak handed buyers from yesterday’s H.C. W coverage are discovering this is a thin stock and they’re pounding out with 70K total volume traded.. this will turn back up IMO. Amateur hour.
1 · Reply
highnihilism
highnihilism Oct. 1 at 9:22 AM
$KBR KBR Trade Count: 20 | Total $: 6.5 K | 0.15 × 90-Day Avg $: 43.6 K | Call $: 3.5 K | Put $: 3.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $XOVR Ershares Private-Public Crossover ETF Trade Count: 11 | Total $: 3.5 K | 0.22 × 90-Day Avg $: 15.7 K | Call $: 3.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $AXGN Axogen Trade Count: 12 | Total $: 4.6 K | 0.17 × 90-Day Avg $: 26.6 K | Call $: 3.5 K | Put $: 1.1 K | % Single-Leg: 72% | % Multi-Leg: 0% | % Contingent: 28% $NVX Novonix Trade Count: 28 | Total $: 46.3 K | 28.62 × 90-Day Avg $: 1.6 K | Call $: 3.5 K | Put $: 42.8 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
JarvisFlow
JarvisFlow Sep. 30 at 10:56 AM
HC Wainwright & Co. updates rating for Axogen ( $AXGN ) to Buy, target set at 25.
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 2:04 AM
Healthcare M&A Takeout / Must-Own Basket: $AXGN $AVTR $ADMA $EVH $SGRY 🔥💪👍💵
1 · Reply
GFstocktwits
GFstocktwits Sep. 29 at 12:46 PM
$AXGN why buy a "second runner", take a look at RNV on the asx when you feel like it
0 · Reply
dustin1101
dustin1101 Sep. 24 at 7:40 PM
$AXGN Just keep buying the dips.. Added back what I sold 17.65 at 17.10 today. Steady freight train momentum as buyers continue to slowly accumulate.
0 · Reply
highnihilism
highnihilism Sep. 24 at 7:10 PM
Russell 2000 (Healthcare) → $AXGN Axogen $BMRN BioMarin Pharmaceutical $CDMO Avid Bioservices $CGEN Compugen $CHCO Community Health Systems
0 · Reply
healthcareguru
healthcareguru Sep. 24 at 2:11 PM
$EVH getting ready to sell themselves to a strategic, clearly…deleveraging, FCF improving, guidance derisked. MUST OWN M&A Basket!! 🔥💪💵 $ADMA $AXGN $AVTR $SGRY
1 · Reply
highnihilism
highnihilism Sep. 24 at 12:32 PM
Russell 2000 (Healthcare) → $AXGN Axogen $BMRN BioMarin Pharmaceutical $CDMO Avid Bioservices $CGEN Compugen $CHCO Community Health Systems
0 · Reply
LuckEtradER
LuckEtradER Sep. 24 at 1:13 AM
$AXGN cup and handle… we’re primed for that lead in to December approval which I bet comes sooner
0 · Reply
healthcareguru
healthcareguru Sep. 23 at 2:43 PM
Better Load Up That M&A Basket…don’t be too late! $AXGN $EVH $AVTR $SGRY $ADMA 💵🔥👍
1 · Reply
hidjay01
hidjay01 Sep. 20 at 9:08 AM
$AXGN 30 dollars soon
0 · Reply
healthcareguru
healthcareguru Sep. 19 at 5:07 PM
REMINDER: Top Healthcare M&A Candidates…these are “Must Owns” in your diversified portfolio… $ADMA $AVTR $SGRY $EVH $AXGN
3 · Reply
LuckEtradER
LuckEtradER Sep. 18 at 5:03 PM
0 · Reply
highnihilism
highnihilism Sep. 16 at 7:09 PM
IWM: Russell 2000 → $AXGN Axogen $RWT Redwood Trust $DAKT Daktronics $NPO Enpro $ARCB Arcbest
0 · Reply
healthcareguru
healthcareguru Sep. 15 at 2:02 PM
Top Healthcare M&A Takeout Picks: $EVH $AVTR $AXGN $SGRY $ADMA 🔥💪💵
2 · Reply
LuckEtradER
LuckEtradER Sep. 12 at 1:35 AM
$AXGN 👀
0 · Reply
dustin1101
dustin1101 Sep. 11 at 6:07 PM
$AXGN Next levels.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 10:59 AM
$AXGN Excellent article that nails exactly where AXGN stands right now. So if you want to update your AXGN knowledge or get acquainted with AXGN, this is a must read. https://beyondspx.com/quote/AXGN/analysis/axogen-a-biologic-catalyst-for-nerve-regeneration-s-next-growth-phase-nasdaq-axgn
0 · Reply